Navigation Links
Model identifies genes that induce normal skin cells to become abnormal

Northwestern University researchers have developed a novel, three-dimensional model that allows scientists to observe how interacting with the microenvironment of metastatic melanoma cells induces normal skin cells to become similar to aggressive cancer cells that migrate and spread throughout the body.

The model, developed by Mary J. C. Hendrix and colleagues at Children's Memorial Research Center, consists of a three-dimensional collagen matrix preconditioned by malignant melanoma cells. Hendrix is president and scientific director of the Children's Memorial Research Center, professor of pediatrics at Northwestern University Feinberg School of Medicine and a member of the executive committees of The Robert H. Lurie Comprehensive Cancer Center and the Center for Genetic Medicine at Northwestern University.

The model was described in an article in the Nov. 15 issue of Cancer Research.

"Our findings offer new insights into the influence of the tumor cell microenvironment on the transformation of normal skin cells, as well as on genetic triggering mechanisms and signaling pathways that could be targeted for novel therapeutic strategies to inhibit the spread of melanoma," Hendrix said.

Metastatic cancer cells are characterized by increased tumor cell invasion and migration, as well as an undifferentiated, or "plastic," nature.

The Hendrix lab has hypothesized that this poorly differentiated cell type serves as an advantage to aggressive cancer cells by enhancing their ability to metastasize virtually undetected by the immune system. The group's current study tested the hypothesis that the microenvironment of metastatic melanoma cells could induce benign skin cells to become cancer-like.

The researchers seeded a particularly aggressive form of human metastatic melanoma cells onto a three-dimensional collagen matrix and allowed the cells to precondition the microenvironment for several days. The malignant melanoma cells were removed and the matrix was left intact.

Then, normal human skin cells were seeded onto the melanoma-preconditioned matrix and were allowed to remain for several days.

After this period, the previously normal cells seeded onto the matrix preconditioned by the metastatic melanoma were reprogrammed to express genes (produce specific gene proteins) associated with a highly plastic cell type similar to the aggressive melanoma cells used in the study.

Removal of the "transdifferentiated" skin cells from the melanoma microenvironment caused the cells to revert to their original appearance.

"There were no significant genetic changes between normal skin cells grown on an untreated matrix and those exposed to a matrix preconditioned by human metastatic melanoma cells, further supporting the hypothesis that "epigenetic" induction of changes in skin cell gene expression is directly related to exposure to the metastatic microenvironment," the authors said.

Hendrix's co-researchers on the study were Elizabeth A. Seftor; Kevin M. Brown; Lynda Chin; Dawn A. Kirshmann; William W. Wheaton; Alexei Protopopov; Bin Feng; Yoganand Balagurunathan; Jeffrey M. Trent; Brian J. Nickoloff; and Richard E. B. Seftor, from Northwestern University; Harvard Medical School; Tgen; and Loyola University.


'"/>

Source:Northwestern University


Related biology news :

1. Study Models Impact Of Anthrax Vaccine
2. Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer
3. Asleep in the deep: Model helps assess ocean-injection strategy for combating greenhouse effect
4. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
5. New lab technique identifies high levels of pathogens in therapy pool
6. Study identifies gene in mice that may control risk-taking behavior in humans
7. Researcher at UGA College of Veterinary Medicine identifies new way of combating viral diseases
8. U. of Colorado researcher identifies tracks of swimming dinosaur in Wyoming
9. New study identifies key gene in development of connections between brain and spinal cord
10. New HIV study identifies high-risk subgroups of adolescents
11. Research identifies protein in mice that regulates bone formation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... , Dec. 6, 2016 Securus ... justice technology solutions for public safety, investigation, corrections ... jointly announced today a five (5) year funding ... agreement to expand the rehabilitation and reentry support ... PEP History Established in 2004, the Prison Entrepreneurship ...
(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we spend ... recovery so we need to do it well. Inadequate sleep levels have been found ... pressure, stroke, diabetes, and even cancer. Maybe now is the best time ... could help them to manage their sleep quality? Continue ... ...
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s ... ... DERMALOG is Germany's largest Multi-Biometric ... Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's Fingerprint Identification System is ...
Breaking Biology News(10 mins):
(Date:12/9/2016)... ... 09, 2016 , ... There’s a winning streak at Voxx Analytics: the tech ... after winning the award last year as well. Employees nominate their companies for the ... Vesely pointed to the tech company’s upbeat environment as a reason. “We don’t answer ...
(Date:12/9/2016)... ... 09, 2016 , ... Aditya Humad, Acting CFO of AxioMed and Managing Partner ... United States, Axiomed is now gaining interest from Silicon Valley. “It was satisfying to ... went on to say that, “We expect interest to continue to rise as AxioMed ...
(Date:12/9/2016)... PHILADELPHIA , Dec. 9, 2016  A ... Temple University are moving one step closer to ... orthopedic applications. OrthoMend Research, Inc., a start-up company ... acquired the exclusive license for these novel absorbable ... to develop them for commercial use. The company ...
(Date:12/9/2016)... - Portage Biotech Inc. ("Portage" or "the Company") (OTC: ... that Biohaven has issued today the following press release: ... (PRWEB) Dec 9, 2016 - Biohaven Pharmaceutical Holding Company ... U.S. Food and Drug Administration ("FDA") has granted the ... BHV-0223, an orally dissolving tablet being developed for the ...
Breaking Biology Technology: